Home
About Us
Leadership
Science & Technology
Pipeline
Careers
News
Contact Us
Contact Us
Português
English
News
April 15, 2025
Antharis Therapeutics Honored with GHP Innovation Excellence Award of the Year 2025
January 27, 2025
Antharis Therapeutics Elected Monoclonal Antibodies Development Company of the Year 2025
January 22, 2025
Antharis Therapeutics’ Dr. Raphael Ribeiro-Pinaud Named Most Iconic Business Leader of 2025
November 18, 2024
Antharis Therapeutics Appoints Patric Nelson as Chief Business Officer
November 7, 2024
Antharis Therapeutics CEO, Dr. Raphael Ribeiro-Pinaud, Featured in Biotech Leader Spotlight Series
October 15, 2024
Antharis Therapeutics Welcomes Daniel Yazbeck as Head of Corporate Strategy
March 18, 2024
Antharis Therapeutics CEO Dr. Raphael Ribeiro-Pinaud Named Among “Most Impactful CEOs of the Year 2024" by CIO Today
February 19, 2024
Antharis Therapeutics Awarded “Biopharmaceutical Company of the Year 2024 - California” by Global Health and Pharma
February 10, 2024
Antharis Therapeutics Recognized as a Leading Emerging Biopharmaceutical Company
January 15, 2024
Antharis Therapeutics CEO, Dr. Raphael Ribeiro-Pinaud, Named “Most Inpiring Business Leader of 2024” by CXO Outlook for Pioneering Advances in Biopharma Innovation
December 18, 2023
Antharis Therapeutics Selected as a Top 10 Biotech Startup in 2023 by Pharma Tech Outlook for Pioneering Immuno-Oncological Cancer Treatments
August 23, 2023
Antharis Therapeutics Acquires Galileo Biotech, including Its GMP-Certified Development and Manufacturing Facility
July 14, 2022
Antharis Therapeutics Acquires Cassyni Biopharma and Its Portfolio of Assets
July 14, 2022
Antharis Therapeutics Announces Successful Completion of Its Series A Financing Round
